+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

2019 Spinal Stenosis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • PDF Icon

    Report

  • 95 Pages
  • April 2019
  • Region: Global
  • VPA Research
  • ID: 4767829
UP TO OFF until Jan 05th 2023
The global clinical trial report- “2019 Spinal Stenosis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Spinal Stenosis. It presents in-depth analysis of Spinal Stenosis clinical trials across markets and companies. The research work is for providing complete understanding into trends in Spinal Stenosis.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Spinal Stenosis clinical trials by:
  • Current Trial Status

  • Type of the trial

  • Sponsor Type

  • Enrollment Trends

  • Region

  • Countries

  • Trial Phase



The report also identifies the potential drug candidates under development for treatment of Spinal Stenosis

The research work is prepared through extensive and continuous research on Spinal Stenosis trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.

  • Drug candidates currently being researched for administering Spinal Stenosis patients are identified

  • The report includes panorama of Spinal Stenosis clinical trials across the globe

  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided

  • Companies and universities focusing on Spinal Stenosis clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)

  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included

  • Both interventional and observational studies are analyzed

  • News and latest developments for the past one year are presented in the report

Table of Contents

1.1 List of Figures1.2 List of Tables
2. Executive Summary
2.1 Spinal Stenosis Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Spinal Stenosis Clinical Trials by Region
2.2.2 Average Enrollment of Spinal Stenosis Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Spinal Stenosis Treatment, 2019
3. Region wise Spinal Stenosis Clinical Trials
3.1 Asia Pacific Spinal Stenosis Clinical Trials by Country
3.2 Europe Spinal Stenosis Clinical Trials by Country
3.3 North America Spinal Stenosis Clinical Trials by Country
3.4 Middle East and Africa Spinal Stenosis Clinical Trials by Country
3.5 South and Central America Spinal Stenosis Clinical Trials by Country
4. Spinal Stenosis Clinical Trial Trends
4.1 Start Year wise Spinal Stenosis Clinical Trials
4.2 Phase wise Spinal Stenosis Clinical Trials
4.3 Trial Status wise Spinal Stenosis Clinical Trials
4.4 Trial Type wise Spinal Stenosis Clinical Trials
5. Spinal Stenosis Average Enrollment Trends
5.1 Average Enrollment in Spinal Stenosis Trials by Year
5.2 Average Enrollment in Spinal Stenosis Trials by Phase
5.3 Average Enrollment in Spinal Stenosis Trials by Status
5.4 Average Enrollment in Spinal Stenosis Trials by Type of Trial
6. Companies Participating in Spinal Stenosis Clinical Trials
6.1 Spinal Stenosis Trials by Sponsor Type
6.2 Spinal Stenosis Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors
7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Spinal Stenosis Trials- Phase 1
7.2 Spinal Stenosis Trials- Phase 2
7.3 Spinal Stenosis Trials- Phase 3
7.4 Spinal Stenosis Trials- Phase 4
8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise
List of Figures
Figure 1: Spinal Stenosis Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Spinal Stenosis Clinical Trials and Enrolment
Figure 5: Europe - Country wise Spinal Stenosis Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Spinal Stenosis Clinical Trials and Enrolment
Figure 7: North America - Country wise Spinal Stenosis Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Spinal Stenosis Clinical Trials and Enrolment
Figure 9: Spinal Stenosis Clinical Trials by Phase
Figure 10: Spinal Stenosis Clinical Trials by Trial Status
Figure 11: Spinal Stenosis Clinical Trials by Type
Figure 12: Spinal Stenosis Clinical Trials by Sponsor Type
Figure 13: Spinal Stenosis Clinical Trials by Leading Sponsors
Figure 14: Spinal Stenosis Average Enrollment by Phase
Figure 15: Spinal Stenosis Average Enrollment by Trial Status
Figure 16: Spinal Stenosis Average Enrollment by Type
Figure 17: Spinal Stenosis- Average Enrolment by Type of Sponsors
Figure 18: Spinal Stenosis- Enrolment by Leading Sponsors
Figure 19: Research Methodology
List of Tables
Table 1: Spinal Stenosis Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Spinal Stenosis Clinical Trials and Enrolment
Table 5: Europe - Country wise Spinal Stenosis Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Spinal Stenosis Clinical Trials and Enrolment
Table 7: North America - Country wise Spinal Stenosis Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Spinal Stenosis Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Spinal Stenosis Average Enrollment by Phase
Table 15: Spinal Stenosis Average Enrollment by Trial Status
Table 16: Spinal Stenosis Average Enrollment by Type
Table 17: Spinal Stenosis- Average Enrolment by Type of Sponsors
Table 18: Spinal Stenosis- Enrolment by Leading Sponsors

Companies Mentioned

  • Aurous HealthCare Research and Development India Pvt Ltd

  • Beijing Tide Pharmaceutical Co Ltd

  • Eli Lilly and Co

  • MallInckrodt Plc

  • Mesoblast Ltd

  • Nippon Zoki Pharmaceutical Co Ltd

  • Organogenesis Inc

  • Pacira Pharmaceuticals Inc

  • Pfizer Inc